Pfizer Limited has announced the appointment of M/s. Kishore Bhatia & Associates as the company’s Cost Auditors for the financial year ending March 31, 2027. The decision was formalized by the Board of Directors following a recommendation from the Audit Committee. The remuneration for these services will be presented to the company’s shareholders for final ratification at the upcoming Annual General Meeting.
New Cost Audit Appointment
Effective May 12, 2026, Pfizer Limited has officially appointed the firm M/s. Kishore Bhatia & Associates to serve as its Cost Auditors. The appointment covers the financial year ending March 31, 2027. This strategic selection is part of the company’s commitment to maintaining robust financial oversight and governance standards.
About the Appointed Firm
M/s. Kishore Bhatia & Associates is a Mumbai-based firm of practicing cost accountants. They bring extensive expertise in a wide range of services including cost audits, certifications, cost consultancy, and the development of costing-based turnaround strategies. The firm possesses a strong track record, having provided services across diverse sectors such as pharmaceuticals, chemicals, engineering, and infrastructure.
Next Steps
While the Board of Directors and the Audit Committee have finalized the selection of the firm, the final remuneration structure remains subject to shareholder approval. The company will place the remuneration details before its shareholders for formal ratification during the next Annual General Meeting.
Source: BSE
